June 24, 2026 09:59 am (IST)
CSE welcomes bread industry's decision to stop using potassium bromate
New Delhi, May 27 (IBNS): Centre for Science and Environment (CSE) has welcomed the announcement made by the All India Bread Manufactures' Association (AIBMA) in a press conference in response to CSE's latest study which had pointed towards widespread use and presence of potassium bromate/iodate residues in bread.
“We have heard what the bread-making association has announced. We are happy that they have decided to stop using potassium bromate and potassium iodate within two-three days. This will reduce public health risk from these chemicals, ” says Chandra Bhushan, deputy director general, CSE.
CSE researchers point out that potassium bromate can possibly cause cancer and use of potassium iodate in bread-making can lead to excess intake of iodine, which could affect thyroid functions.
The FSSAI (Food Safety and Standards Authority of India) has already announced a ban on use of potassium bromate.
“We welcome the FSSAI’s move to ban potassium bromate. Now that the industry has decided not to use both these chemicals in public interest, we urge the FSSAI to also ban use of potassium iodate in bread-making,” says Bhushan.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Sugar causes cancer? Doctor drops bombshell truth that shatters viral Instagram claims
Mon, Jun 22 2026
Could Vitamin C protect your memory? Major study sparks new hope
Sun, Jun 21 2026
Screen time, BMI, and mental health may be linked to sleep quality in Chinese adolescents: Study
Sun, Jun 21 2026
No big cuts, faster healing: Kolkata's BM Birla Heart Hospital launches robotic-assisted heart surgery
Tue, Jun 16 2026
Alembic Pharmaceuticals Limited announces USFDA final approval for Tretinoin Cream USP, 0.05%
Mon, Jun 15 2026
USD 1,000 in the US vs USD 25 in India: American woman’s viral video claims shocking drug price gap
Sat, Jun 13 2026
